Literature DB >> 24433292

Pericardial, intra-abdominal, and subcutaneous adipose tissue in patients with major depressive disorder.

K G Kahl1, K Hueper, U Schweiger, M Gutberlet, A-M Detlef, C Weiss, A von Bohlen, R Pul, R Lichtinghagen, F Wacker, D Hartung.   

Abstract

OBJECTIVE: Major depressive disorder (MDD) is associated with an increased risk for developing coronary artery disease (CAD). Recently, pericardial adipose tissue, a metabolically active visceral fat depot surrounding the heart, has been implicated in the pathogenesis of CAD. Therefore, we investigated pericardial adipose tissue volumes in patients with MDD and compared them to healthy comparison subjects.
METHOD: In this case-control study at a university medical center, 50 male and female in-patients with MDD and 25 healthy men and women were examined. The main outcome measures were the volumes of pericardial adipose tissue, intra-abdominal adipose tissue (IaAT) and subcutaneous adipose tissue (ScAT) which were measured using magnetic resonance imaging.
RESULTS: The pericardial adipose tissue volumes were greater in men and women with MDD compared with the healthy comparison group following adjustments for the effects of age, weight, height, and physical activity.
CONCLUSION: This study expands our knowledge about the alterations in body composition that occur in patients with MDD. The findings are highly relevant for understanding the comorbidity between heart disease and depressive disorders.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cardio-vascular diseases; depression; diabetes mellitus

Mesh:

Year:  2014        PMID: 24433292     DOI: 10.1111/acps.12242

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  7 in total

1.  Increased pericardial adipose tissue and cardiometabolic risk in patients with schizophrenia versus healthy controls.

Authors:  J Ruppert; D Hartung; M Westhoff-Bleck; J Herrmann; B Stubbs; J Cordes; T H C Krüger; R Lichtinghagen; K G Kahl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-11-23       Impact factor: 5.270

2.  Impact of aerobic exercise on muscle mass in patients with major depressive disorder: a randomized controlled trial.

Authors:  Arno Kerling; Dagmar Hartung; Brendon Stubbs; Momme Kück; Uwe Tegtbur; Lena Grams; Thomas Sanjay Weber-Spickschen; Kai G Kahl
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-06       Impact factor: 2.570

Review 3.  Heart and brain interactions : Pathophysiology and management of cardio-psycho-neurological disorders.

Authors:  Renate B Schnabel; Gert Hasenfuß; Sylvia Buchmann; Kai G Kahl; Stefanie Aeschbacher; Stefan Osswald; Christiane E Angermann
Journal:  Herz       Date:  2021-02-05       Impact factor: 1.443

Review 4.  Adipose Tissue Compartments, Inflammation, and Cardiovascular Risk in the Context of Depression.

Authors:  Britta Stapel; Maria Jelinic; Grant R Drummond; Dagmar Hartung; Kai G Kahl
Journal:  Front Psychiatry       Date:  2022-04-04       Impact factor: 5.435

5.  Association between depressive symptoms and pericardial fat in healthy older men and women.

Authors:  Natalie Ella Miller; Andrew Steptoe
Journal:  Sci Rep       Date:  2022-08-17       Impact factor: 4.996

6.  Exercise therapy improves aerobic capacity of inpatients with major depressive disorder.

Authors:  Arno Kerling; Anne von Bohlen; Momme Kück; Uwe Tegtbur; Lena Grams; Sven Haufe; Elke Gützlaff; Kai G Kahl
Journal:  Brain Behav       Date:  2016-04-22       Impact factor: 2.708

7.  Fat compartments in patients with depression: A meta-analysis.

Authors:  Alisa S Cosan; Julietta U Schweiger; Kai G Kahl; Bettina Hamann; Michael Deuschle; Ulrich Schweiger; Anna L Westermair
Journal:  Brain Behav       Date:  2020-11-05       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.